INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹14 Cr | ₹-2.75 Cr | ₹3.31 Cr | ₹-6.54 Cr | ₹8.05 Cr |
What is the latest Net Cash Inflow / Outflow ratio of INDOCO REMEDIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹14 Cr |
| Mar2025 | ₹-2.75 Cr |
| Mar2024 | ₹3.31 Cr |
| Mar2023 | ₹-6.54 Cr |
| Mar2022 | ₹8.05 Cr |
How is Net Cash Inflow / Outflow of INDOCO REMEDIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹14 Cr | Positive | |
| Mar2025 | ₹-2.75 Cr | Negative | |
| Mar2024 | ₹3.31 Cr | Positive | |
| Mar2023 | ₹-6.54 Cr | Negative | |
| Mar2022 | ₹8.05 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,246.6 Cr | 8.1% | 10.9% | -12.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 8.1% |
10.9% |
-12.2% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses